<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-21T02:33:38Z</responseDate><request verb="GetRecord" identifier="oai:wakespace.lib.wfu.edu:10339/59288" metadataPrefix="dim">https://wakespace.lib.wfu.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:null:10339/59288</identifier><datestamp>2026-09-02T12:15:00Z</datestamp><setSpec>com_10339_14934</setSpec><setSpec>col_10339_38132</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Lehman, Christine Lehman</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2016-05-21T08:35:41Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2018-05-20T08:30:11Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2016</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://wakespace.lib.wfu.edu/handle/10339/59288</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Cancer development is often initiated by various genetic abnormalities including chromosomal translocations which require DNA breakage.  These DNA breaks can occur through exogeneous chemical exposures and/or at regions particularly susceptible to breakage termed “common fragile sites (CFS)”.  To test the hypothesis that fragile site breakage underlies the formation of chromosomal rearrangements, we focused on RET/PTC rearrangements in papillary thyroid carcinoma.  All genes participating in the two most common types of RET/PTC rearrangements, RET/PTC1 and RET/PTC3, are located within common fragile sites. Fragile sites are sensitive to a variety of environmental chemicals and chemotherapeutic drugs and we have shown that treatment of human thyroid cells with laboratory fragile site-inducing chemicals can cause the formation of RET/PTC rearrangement.   Here, we demonstrate that treatment with non-cytotoxic levels of environmental chemicals, benzene and diethylnitrosamine, and chemotherapeutic agents, etoposide and doxorubicin, generate significant DNA breakage within RET at levels similar to those generated by laboratory fragile site-inducing chemicals. These results suggest the role of long-term exposure to these chemicals in the generation of RET/PTC rearrangements.  DNA topoisomerases I and II maintain structural integrity by recognizing and cleaving DNA secondary structures such as those at fragile sites.  Co-treatment of human thyroid cells with APH and topoisomerase inhibitors significantly altered APH-induced breakage within RET demonstrating their involvement in initiating APH-induced breakage at RET.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en_US">Wake Forest University</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Benzene</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Cancer</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">DNA break</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">RET/PTC</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Thyroid</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Topoisomerase</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">DNA FRAGILE SITE BREAKAGE AS A MEASURE OF CHEMICAL EXPOSURE AND PREDICTOR OF THE SUSCEPTIBILITY TO FORM CHROMOSOMAL REARRANGEMENTS</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Dissertation</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeChair" lang="en_US">Wang, Yuh-Hwa</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Hollis, Thomas</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Miller, Mark</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Ornelles, David</dim:field>
   <dim:field mdschema="thesis" element="contributor" qualifier="committeeMember" lang="en_US">Pardee, Timothy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline" lang="en_US">Cancer Biology</dim:field>
   <dim:field mdschema="thesis" element="embargo" qualifier="terms" lang="en_US">2018-05-20</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>